We recently highlighted the discriminating role of a “two-hits” immunohistochemical panel consisting of Claudin-4 and BAP1 [3]; combining two or more different markers may represent the best compromise when using the special stains to distinguish mesothelioma with epithelioid features from conventional metastatic carcinoma. The gene discussed is CLDN4; the disease is metastatic carcinoma.